PMC:7600245 / 36622-36733 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T136","span":{"begin":102,"end":110},"obj":"Disease"}],"attributes":[{"id":"A136","pred":"mondo_id","subj":"T136","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Thus, HCV protease inhibitors, including danoprevir, have been proposed as potential therapeutics for COVID-19."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T559","span":{"begin":10,"end":29},"obj":"Chemical"},{"id":"T561","span":{"begin":19,"end":29},"obj":"Chemical"}],"attributes":[{"id":"A559","pred":"chebi_id","subj":"T559","obj":"http://purl.obolibrary.org/obo/CHEBI_37670"},{"id":"A560","pred":"chebi_id","subj":"T559","obj":"http://purl.obolibrary.org/obo/CHEBI_60258"},{"id":"A561","pred":"chebi_id","subj":"T561","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"Thus, HCV protease inhibitors, including danoprevir, have been proposed as potential therapeutics for COVID-19."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T273","span":{"begin":0,"end":111},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, HCV protease inhibitors, including danoprevir, have been proposed as potential therapeutics for COVID-19."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1112","span":{"begin":41,"end":51},"obj":"Chemical"},{"id":"1119","span":{"begin":102,"end":110},"obj":"Disease"}],"attributes":[{"id":"A1112","pred":"tao:has_database_id","subj":"1112","obj":"MESH:C553752"},{"id":"A1119","pred":"tao:has_database_id","subj":"1119","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Thus, HCV protease inhibitors, including danoprevir, have been proposed as potential therapeutics for COVID-19."}